Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Advanced Drug Delivery Reviews

• Publication date

  2013-05-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.addr.2012.07.013PMID 22921597
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Braunwald's Heart Disease: a textbook of cardiovascular medicine volume 1

  2015cited by this paper
• Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

  2012cited by this paper
• Tailoring of biomimetic high-density lipoprotein nanostructures changes cholesterol binding and efflux.

  2012influential reference
• Amphotericin B use in children: conventional and lipid-based formulations

  2011cited by this paper
• The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis.

  2011influential reference
• Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery.

  2011influential reference
• MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins

  2011cited by this paper
• Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 10th Edition

  2011cited by this paper
• Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

  2011cited by this paper
• Treatment of acute promyelocytic leukemia without cytotoxic chemotherapy.

  2011cited by this paper
• D-4F, an apoA-1 mimetic, decreases airway hyperresponsiveness, inflammation, and oxidative stress in a murine model of asthma[S]

  2011cited by this paper
• Curcumin nanodisk-induced apoptosis in mantle cell lymphoma

  2011cited by this paper
• Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles.

  2011influential reference
• Curcumin nanodisks: formulation and characterization.

  2011cited by this paper
• Efficient cytosolic delivery of siRNA using HDL-mimicking nanoparticles.

  2011cited by this paper
• Haemolysis during Sample Preparation Alters microRNA Content of Plasma

  2011cited by this paper
• Metabolic and functional relevance of HDL subspecies

  2011cited by this paper
• Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA.

  2011cited by this paper
• The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability.

  2010cited by this paper
• Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities

  2010cited by this paper
• Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats

  2010cited by this paper
• All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma

  2010cited by this paper
• Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer.

  2010cited by this paper
• The Role of High-Density Lipoproteins in Reducing the Risk of Vascular Diseases, Neurogenerative Disorders, and Cancer

  2010cited by this paper
• Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration‐resistant prostate cancer in a mouse xenograft model

  2010cited by this paper
• Heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Nanotechnology for synthetic high-density lipoproteins.

  2010cited by this paper
• HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting.

  2010cited by this paper
• Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles.

  2010cited by this paper
• Structure and function of HDL mimetics.

  2010cited by this paper
• Apolipoprotein A-I Mimetic Peptides: A Potential New Therapy for the Prevention of Atherosclerosis

  2010cited by this paper
• Apolipoprotein A-I structural organization in high density lipoproteins isolated from human plasma

  2010cited by this paper
• Future Therapeutic Directions in Reverse Cholesterol Transport

  2010cited by this paper
• Transfection of pancreatic islets using polyvalent DNA-functionalized gold nanoparticles.

  2010cited by this paper
• [Laboratory assessment of HDL heterogeneity and function].

  2009cited by this paper
• Comparison of synthetic high density lipoprotein (HDL) contrast agents for MR imaging of atherosclerosis.

  2009cited by this paper
• Reconstituted HDL: a therapy for atherosclerosis and beyond

  2009cited by this paper
• The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic.

  2009cited by this paper
• Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier

  2009influential reference
• Biomimetic nanocarrier for direct cytosolic drug delivery.

  2009cited by this paper
• Knocking down barriers: advances in siRNA delivery

  2009cited by this paper
• The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis This work was supported by P01-HL22633 from the NHLBI. Published, JLR Papers in Press, December 8, 2008.

  2009influential reference
• Gene regulation with polyvalent siRNA-nanoparticle conjugates.

  2009cited by this paper
• A reconstituted HDL containing V156K or R173C apoA-I exhibited anti-inflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation

  2009cited by this paper
• Development of lipidoid-siRNA formulations for systemic delivery to the liver.

  2009cited by this paper
• Templated spherical high density lipoprotein nanoparticles.

  2009cited by this paper
• Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.

  2009cited by this paper
• Nanoparticle therapeutics: an emerging treatment modality for cancer

  2008influential reference
• Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel

  2008influential reference
• Is raising HDL a futile strategy for atheroprotection?

  2008cited by this paper
• An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection.

  2008cited by this paper
• High-density lipoprotein cholesterol and venous thromboembolism in the Longitudinal Investigation of Thromboembolism Etiology (LITE).

  2008cited by this paper
• Laboratory assessment of HDL heterogeneity and function.

  2008cited by this paper
• Nanodisks: hydrophobic drug delivery vehicles

  2008cited by this paper
• Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles

  2008cited by this paper
• Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform.

  2008cited by this paper
• Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes

  2008influential reference
• Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque

  2008influential reference
• Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

  2007cited by this paper
• Effects of torcetrapib in patients at high risk for coronary events.

  2007cited by this paper
• 6.20 – Atherosclerosis/Lipoprotein/Cholesterol Metabolism

  2007cited by this paper
• Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines

  2007cited by this paper
• Effects of Reconstituted High-density Lipoprotein Infusions on Coronary Atherosclerosis

  2007cited by this paper
• All-trans-retinoic acid nanodisks.

  2007cited by this paper
• Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.

  2007cited by this paper
• Mechanisms and optimization of in vivo delivery of lipophilic siRNAs

  2007cited by this paper
• Antiatherogenic small, dense HDL—guardian angel of the arterial wall?

  2006cited by this paper
• Efficient suppression of secretory clusterin levels by polymer-siRNA nanocomplexes enhances ionizing radiation lethality in human MCF-7 breast cancer cells in vitro*

  2006cited by this paper
• Toxic Potential of Materials at the Nanolevel

  2006cited by this paper
• Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing.

  2006cited by this paper
• Pathogenesis of atherosclerosis.

  2006cited by this paper
• Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B Published, JLR Papers in Press, November 28, 2005.

  2006cited by this paper
• Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging.

  2006influential reference
• Molecular regulation of HDL metabolism and function: implications for novel therapies.

  2006cited by this paper
• Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial

  2005cited by this paper
• Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia

  2005cited by this paper
• Fully 2'-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA.

  2005cited by this paper
• ABCA1 and ABCG1 Synergize to Mediate Cholesterol Export to ApoA-I

  2005cited by this paper
• Role of cholesterol and lipid organization in disease

  2005cited by this paper
• High-Density Lipoprotein Promotes Endothelial Cell Migration and Reendothelialization via Scavenger Receptor-B Type I

  2005cited by this paper
• Cholesteryl esters in malignancy.

  2005cited by this paper
• Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques.

  2004influential reference
• PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles.

  2004cited by this paper
• Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells.

  2004cited by this paper
• HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.

  2004cited by this paper
• HDL: the metabolism, function, and therapeutic importance.

  2004cited by this paper
• Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

  2004cited by this paper
• Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity.

  2004cited by this paper
• High-Density Lipoprotein Subpopulation Profile and Coronary Heart Disease Prevalence in Male Participants of the Framingham Offspring Study

  2004cited by this paper
• ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.

  2004influential reference
• Distribution spectrum of paraoxonase activity in HDL fractions.

  2004cited by this paper
• Differential Regulation of Steroid Hormone Biosynthesis in R2C and MA-10 Leydig Tumor Cells: Role of SR-B1-Mediated Selective Cholesteryl Ester Transport1

  2003cited by this paper
• The Spatial Organization of Apolipoprotein A-I on the Edge of Discoidal High Density Lipoprotein Particles

  2003cited by this paper
• Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.

  2003cited by this paper
• Oral Administration of an Apo A-I Mimetic Peptide Synthesized From D-Amino Acids Dramatically Reduces Atherosclerosis in Mice Independent of Plasma Cholesterol

  2002cited by this paper
• Rapid endo‐lysosomal escape of poly(DL‐lactide‐coglycolide) nanoparticles: implications for drug and gene delivery

  2002cited by this paper
• HDL and arteriosclerosis: beyond reverse cholesterol transport.

  2002cited by this paper
• High Density Lipoprotein (HDL) Particle Uptake Mediated by Scavenger Receptor Class B Type 1 Results in Selective Sorting of HDL Cholesterol from Protein and Polarized Cholesterol Secretion*

  2001influential reference
• High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

  2001cited by this paper

• High-density lipoprotein nanoparticles spontaneously target to damaged renal tubules and alleviate renal fibrosis by remodeling the fibrotic niches

  2025cites this paper
• Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease

  2025cites this paper
• High-density lipoprotein-based nanoplatforms for macrophage-targeted diagnosis and therapy of atherosclerosis.

  2025cites this paper
• Serum albumin nanoparticles: Ligand functionalization for enhanced targeted therapeutics in precision medicine

  2025cites this paper
• Bioengineering approaches to trained immunity: Physiologic targets and therapeutic strategies

  2025cites this paper
• Exploring the Potential of Non-Viral Nanocarriers for Improving Blood-Brain Barrier Permeability to Enhance the Treatment of Brain Diseases

  2025cites this paper
• Lymph-targeted high-density lipoprotein-mimetic nanovaccine for multi-antigenic personalized cancer immunotherapy

  2024cites this paper
• Intracellular cholesterol efflux effects of mannose-beta cyclodextrin conjugates on cholesterol-laden foam cells

  2024cites this paper
• Nanotechnology Based Therapeutic Approach in Alzheimer's

  2024cites this paper
• Therapeutic potentials of peptide-derived nanoformulations in atherosclerosis: present status and future directions

  2024cites this paper
• Sonogenetics in the Treatment of Chronic Diseases: A New Method for Cell Regulation

  2024cites this paper
• Overcoming endosomal/lysosomal barriers: Advanced strategies for cytosolic siRNA delivery

  2024cites this paper
• Prediction model for ocular metastasis of breast cancer: machine learning model development and interpretation study

  2024cites this paper
• Recent progress of nanomedicine in the treatment of Alzheimer’s disease

  2023cites this paper
• Recent Advances in Anti‐Atherosclerosis and Potential Therapeutic Targets for Nanomaterial‐Derived Drug Formulations

  2023cites this paper
• The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy

  2022cites this paper
• Advancements in cell membrane camouflaged nanoparticles: A bioinspired platform for cancer therapy.

  2022cites this paper
• Surface Modification of Lipid-Based Nanoparticles.

  2022cites this paper
• Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential

  2022cites this paper
• A green-inspired method to prepare non-split high-density lipoprotein (HDL) carrier with anti-dysfunctional activities superior to reconstituted HDL.

  2022cites this paper
• Nanotheranostics for Image-Guided Cancer Treatment

  2022cites this paper
• Recent Development of LDL-Based Nanoparticles for Cancer Therapy

  2022cites this paper
• Recent Advances in the Development of Theranostic Nanoparticles for Cardiovascular Diseases

  2021cites this paper
• Low-density lipoprotein nanomedicines: mechanisms of targeting, biology, and theranostic potential

  2021cites this paper
• Exploring the Therapeutic Potential of the Bioinspired Reconstituted High Density Lipoprotein Nanostructures.

  2021cites this paper
• Mimic Lipoproteins Responsive to Intratumoral pH and Allosteric Enzyme for Efficient Tumor Therapy.

  2021cites this paper
• Nanotechnological approach to delivering nutraceuticals as promising drug candidates for the treatment of atherosclerosis

  2021cites this paper
• Protein-Based Nanoparticles as Drug Delivery Systems

  2020cites this paper
• Cholesterol‐conjugated bovine serum albumin nanoparticles as a tamoxifen tumor‐targeted delivery system

  2020cites this paper
• Non-viral Vectors for Gene Therapy

  2020cites this paper
• Endocytic recycling as cellular trafficking fate of simvastatin-loaded Discoidal reconstituted high-density lipoprotein to coordinate cholesterol efflux and drug influx.

  2020cites this paper
• Reconstituted high density lipoprotein (rHDL), a versatile drug delivery nanoplatform for tumor targeted therapy.

  2020cites this paper
• Bioinspired Nanoparticles for Efficient Drug Delivery System

  2020cites this paper
• High density lipoprotein mimicking nanoparticles for atherosclerosis

  2020cites this paper
• Shuttle/sink model composed of β-cyclodextrin and simvastatin-loaded discoidal reconstituted high-density lipoprotein for enhanced cholesterol efflux and drug uptake in macrophage/foam cells.

  2020cites this paper
• Lipoproteins-nanocarriers as a Promising Approach for Targeting Liver Cancer: Present Status and Application Prospects.

  2020cites this paper
• Clearance of two organic nanoparticles from the brain via the paravascular pathway.

  2020cites this paper
• From Endocytosis to Nonendocytosis: The Emerging Era of Gene Delivery.

  2020cites this paper
• Reconfiguring Nature’s Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents

  2020influential citation
• Nanoparticles based on natural, engineered or synthetic proteins and polypeptides for drug delivery applications.

  2020cites this paper
• Research Progress in Bioinspired Drug Delivery Systems

  2020cites this paper
• Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research

  2019cites this paper
• Encapsulation of anticancer drug curcumin and co-loading with photosensitizer hypericin into lipoproteins investigated by fluorescence resonance energy transfer.

  2019cites this paper
• The role of high‐density lipoproteins in antitumor drug delivery

  2019cites this paper
• Dual Targeted Synthetic Nanoparticle for Cardiovascular Diseases.

  2019cites this paper
• Rational Design of Lovastatin-Loaded Spherical Reconstituted High Density Lipoprotein for Efficient and Safe Anti-Atherosclerotic Therapy.

  2019cites this paper
• Reassembly of native components with donepezil to execute dual‐missions in Alzheimer's disease therapy

  2019cites this paper
• Hybrid lipid-nanoparticle complexes for biomedical applications.

  2019cites this paper
• Precision nanomedicine in atherosclerosis therapy: how far are we from reality?

  2019cites this paper
• Lipoproteins as drug delivery vehicles for cancer and tumor therapeutics

  2018cites this paper
• Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy

  2018cites this paper
• The shape effect of reconstituted high-density lipoprotein nanocarriers on brain delivery and Aβ clearance

  2018cites this paper
• Lysosome-Independent Intracellular Drug/Gene Codelivery by Lipoprotein-Derived Nanovector for Synergistic Apoptosis-Inducing Cancer-Targeted Therapy.

  2018cites this paper
• Targeted Delivery of Bioactive Molecules for Vascular Intervention and Tissue Engineering

  2018cites this paper
• Influence of Fatty Acid Modification on Uptake of Lovastatin-Loaded Reconstituted High Density Lipoprotein by Foam Cells

  2018cites this paper
• Probing the Effect of Bioinspired Nanomaterials on Angiogenic Sprouting With a Microengineered Vascular System

  2018cites this paper
• Evaluation of the Combined Effect of Recombinant High-Density Lipoprotein Carrier and the Encapsulated Lovastatin in RAW264.7 Macrophage Cells Based on the Median-Effect Principle.

  2018cites this paper
• Synthetic high‐density lipoprotein nanoconjugate targets neuroblastoma stem cells, blocking migration and self‐renewal☆

  2018cites this paper
• Rationally designed ligand‐independent peptide inhibitors of TREM‐1 ameliorate collagen‐induced arthritis

  2017cites this paper
• High-Density Lipoprotein-like Magnetic Nanostructures (HDL-MNS): Theranostic Agents for Cardiovascular Disease

  2017cites this paper
• Natural Particulates Inspired Specific-Targeted Codelivery of siRNA and Paclitaxel for Collaborative Antitumor Therapy.

  2017cites this paper
• Reconstituted high-density lipoproteins: novel biomimetic nanocarriers for drug delivery

  2017cites this paper
• Atheromarkers of high-density lipoproteins. Part II. Impairments in the composition, structure, and functions of high-density lipoproteins as both the cause of their atherogenic properties and their atheromarkers: a review of literature

  2017cites this paper
• Serum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC)

  2017cites this paper
• Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy

  2017cites this paper
• Overcoming T. gondii infection and intracellular protein nanocapsules as biomaterials for ultrasonically controlled drug release.

  2017cites this paper
• Biofunctional Polymer-Lipid Hybrid High-Density Lipoprotein-Mimicking Nanoparticles Loading Anti-miR155 for Combined Antiatherogenic Effects on Macrophages.

  2017cites this paper
• Engineered nanoparticles for the detection, treatment and prevention of atherosclerosis: how close are we?

  2017cites this paper
• Targeted Biomimetic Nanoparticles for Synergistic Combination Chemotherapy of Paclitaxel and Doxorubicin.

  2017cites this paper
• Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting.

  2017cites this paper
• Self-Assembling Cyclic d,l-α-Peptides as Modulators of Plasma HDL Function. A Supramolecular Approach toward Antiatherosclerotic Agents

  2017cites this paper
• Nanoparticles Based on Plasma Proteins for Drug Delivery Applications.

  2016cites this paper
• High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

  2016cites this paper
• Evaluation of reconstituted high-density lipoprotein (rHDL) as a drug delivery platform - a detailed survey of rHDL particles ranging from biophysical properties to clinical implications.

  2016cites this paper
• Biomimetic HDL nanoparticle mediated tumor targeted delivery of indocyanine green for enhanced photodynamic therapy.

  2016cites this paper
• Lipoprotein Like Nanoparticles Used in Drug and Gene Delivery.

  2016cites this paper
• Green design "bioinspired disassembly-reassembly strategy" applied for improved tumor-targeted anticancer drug delivery.

  2016cites this paper
• Targeting and therapeutic peptides in nanomedicine for atherosclerosis

  2016cites this paper
• Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma

  2016cites this paper
• Development of a validated LC-APCI-MS/MS method to study the plasma and tumor distribution of CHO-PTX intravenous lipid emulsion.

  2016cites this paper
• Nanotechnology inspired tools for mitochondrial dysfunction related diseases.

  2016cites this paper
• Lipoproteins and lipoprotein mimetics for imaging and drug delivery.

  2016cites this paper
• Pathways for Modulating Exosome Lipids Identified By High-Density Lipoprotein-Like Nanoparticle Binding to Scavenger Receptor Type B-1

  2016cites this paper
• A high-density lipoprotein-mediated drug delivery system.

  2016influential citation
• Facile synthesis of yolk-shell silica nanoparticles for targeted tumor therapy.

  2015cites this paper
• Recent Advances in Targeted, Self‐Assembling Nanoparticles to Address Vascular Damage Due to Atherosclerosis

  2015cites this paper
• Synthetic high-density lipoprotein-like nanoparticles as cancer therapy.

  2015cites this paper
• Suppression of Remodeling Behaviors with Arachidonic Acid Modification for Enhanced in vivo Antiatherogenic Efficacies of Lovastatin-loaded Discoidal Recombinant High Density Lipoprotein

  2015cites this paper
• Facilitated preparation of bioconjugatable zwitterionic quantum dots using dual-lipid encapsulation.

  2015cites this paper
• Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein

  2015cites this paper
• Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging

  2015cites this paper
• Reconstituted high density lipoprotein-based nanoparticles: an overview of applications in regenerative medicine, preparation, evaluation and future trends.

  2015cites this paper
• Theranostic lipid nanoparticles for cancer medicine.

  2015cites this paper
• Effect of Hyp delivery system on PKCα activity: What will happen after pkcα gene silencing and Hyp photo-activation?

  2015cites this paper
• Synthetic high-density lipoprotein-like nanoparticles for cancer therapy

  2015cites this paper
• Searching for a successful HDL-based treatment strategy.

  2014cites this paper
• High-density lipoproteins for the systemic delivery of short interfering RNA

  2014cites this paper
• Arachidonic Acid-Modified Lovastatin Discoidal Reconstituted High Density Lipoprotein Markedly Decreases the Drug Leakage during the Remodeling Behaviors Induced by Lecithin Cholesterol Acyltransferase

  2014cites this paper
• Kinetics of incorporation/redistribution of photosensitizer hypericin to/from high-density lipoproteins.

  2014cites this paper
• Incorporation of photosenzitizer hypericin into synthetic lipid-based nano-particles for drug delivery and large unilamellar vesicles with different content of cholesterol

  2014influential citation